38 related articles for article (PubMed ID: 9885980)
1. Collateral Lethality: A new therapeutic strategy in oncology.
Muller FL; Aquilanti EA; DePinho RA
Trends Cancer; 2015 Nov; 1(3):161-173. PubMed ID: 26870836
[TBL] [Abstract][Full Text] [Related]
2. An unbalanced translocation involving loss of 10q26.2 and gain of 11q25 in a pedigree with autism spectrum disorder and cerebellar juvenile pilocytic astrocytoma.
Minhas HM; Pescosolido MF; Schwede M; Piasecka J; Gaitanis J; Tantravahi U; Morrow EM
Am J Med Genet A; 2013 Apr; 161A(4):787-91. PubMed ID: 23495067
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review).
Zhang X; Zhang W; Cao WD; Cheng G; Zhang YQ
Exp Ther Med; 2012 Jan; 3(1):9-14. PubMed ID: 22969836
[TBL] [Abstract][Full Text] [Related]
4. Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric Glioblastomas.
Muñoz J; Inda MM; Lázcoz P; Zazpe I; Fan X; Alfaro J; Tuñón T; Rey JA; Castresana JS
ISRN Neurol; 2012; 2012():576578. PubMed ID: 22389839
[TBL] [Abstract][Full Text] [Related]
5. Allelic loss of 10q23.3, the PTEN gene locus in cervical carcinoma from Northern Indian population.
Rizvi MM; Alam MS; Mehdi SJ; Ali A; Batra S
Pathol Oncol Res; 2012 Apr; 18(2):309-13. PubMed ID: 21901275
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Survival of a Patient with Giant Cell Glioblastoma: Case Report and Review of the Literature.
Naydenov E; Bussarsky V; Nachev S; Hadjidekova S; Toncheva D
Case Rep Oncol; 2009 Jul; 2(2):103-110. PubMed ID: 20740171
[TBL] [Abstract][Full Text] [Related]
7. Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas.
Liu J; Lu H; Ohgaki H; Merlo A; Shen Z
BMC Cancer; 2009 Aug; 9():268. PubMed ID: 19653894
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas.
Li JY; Wang H; May S; Song X; Fueyo J; Fuller GN; Wang H
J Neurooncol; 2008 May; 88(1):11-7. PubMed ID: 18246408
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen distribution analysis in North Italian brain Glioma patients: an association with HLA-DRB1*14.
Guerini FR; Agliardi C; Zanzottera M; Delbue S; Pagani E; Tinelli C; Boldorini R; Car PG; Veggiani C; Ferrante P
J Neurooncol; 2006 Apr; 77(2):213-7. PubMed ID: 16314951
[TBL] [Abstract][Full Text] [Related]
10. Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis.
Goessel G; Quante M; Hahn WC; Harada H; Heeg S; Suliman Y; Doebele M; von Werder A; Fulda C; Nakagawa H; Rustgi AK; Blum HE; Opitz OG
Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15599-604. PubMed ID: 16239349
[TBL] [Abstract][Full Text] [Related]
11. PAX6 suppresses growth of human glioblastoma cells.
Zhou YH; Wu X; Tan F; Shi YX; Glass T; Liu TJ; Wathen K; Hess KR; Gumin J; Lang F; Yung WK
J Neurooncol; 2005 Feb; 71(3):223-9. PubMed ID: 15735909
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of transfected PTEN on human colon cancer.
Xu SS; Shen WL; Ouyang SY
World J Gastroenterol; 2004 Dec; 10(24):3670-3. PubMed ID: 15534929
[TBL] [Abstract][Full Text] [Related]
13. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.
Brat DJ; Seiferheld WF; Perry A; Hammond EH; Murray KJ; Schulsinger AR; Mehta MP; Curran WJ;
Neuro Oncol; 2004 Apr; 6(2):96-103. PubMed ID: 15134623
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas.
Terada K; Tamiya T; Daido S; Kambara H; Tanaka H; Ono Y; Matsumoto K; Ito S; Ouchida M; Ohmoto T; Shimizu K
J Neurooncol; 2002 Jun; 58(2):107-14. PubMed ID: 12164681
[TBL] [Abstract][Full Text] [Related]
15. Functional and molecular analyses of 10q deletions in human gliomas.
Steck PA; Lin H; Langford LA; Jasser SA; Koul D; Yung WK; Pershouse MA
Genes Chromosomes Cancer; 1999 Feb; 24(2):135-43. PubMed ID: 9885980
[TBL] [Abstract][Full Text] [Related]
16. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
[TBL] [Abstract][Full Text] [Related]
17. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.
Lin H; Bondy ML; Langford LA; Hess KR; Delclos GL; Wu X; Chan W; Pershouse MA; Yung WK; Steck PA
Clin Cancer Res; 1998 Oct; 4(10):2447-54. PubMed ID: 9796977
[TBL] [Abstract][Full Text] [Related]
18. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.
Sasaki H; Zlatescu MC; Betensky RA; Ino Y; Cairncross JG; Louis DN
Am J Pathol; 2001 Jul; 159(1):359-67. PubMed ID: 11438483
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of malignant gliomas.
Rasheed BK; Wiltshire RN; Bigner SH; Bigner DD
Curr Opin Oncol; 1999 May; 11(3):162-7. PubMed ID: 10328589
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
